相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials
Oumaima El Alaoui El Abdallaoui et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial
Masafumi Ono et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial
Byeong-Keuk Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trial
Daniel Aradi et al.
EUROPEAN HEART JOURNAL (2019)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Bianca Rocca et al.
EUROPEAN HEART JOURNAL (2018)
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
Thomas Cuisset et al.
EUROPEAN HEART JOURNAL (2017)
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
Dirk Sibbing et al.
LANCET (2017)
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial
Dirk Sibbing et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes
Pablo Lamelas et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting
Mathieu Pankert et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
Daniel Aradi et al.
EUROPEAN HEART JOURNAL (2014)
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study
Joseph A. Jakubowski et al.
THROMBOSIS RESEARCH (2014)
Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
分享论文
